Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months.

Zepp, Fred

Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months. [electronic resource] - European journal of pediatrics Aug 2007 - 857-64 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0340-6199

10.1007/s00431-007-0506-z doi


Analysis of Variance
Antibodies, Bacterial--blood
Antibodies, Viral--blood
Chickenpox Vaccine--administration & dosage
Diphtheria-Tetanus-Pertussis Vaccine
Enzyme-Linked Immunosorbent Assay
Female
Fever--chemically induced
Haemophilus Vaccines
Hepatitis B Vaccines
Humans
Immunization Schedule
Immunization, Secondary--adverse effects
Infant
Male
Measles-Mumps-Rubella Vaccine--administration & dosage
Pain--chemically induced
Poliovirus Vaccine, Inactivated
Skin Diseases--chemically induced
Vaccines, Combined--administration & dosage